Utility of cytopathological specimens and an automated image analysis for the evaluation of HER2 status and intratumor heterogeneity in breast carcinoma-Reference-Cited by-同舟云学术

Utility of cytopathological specimens and an automated image analysis for the evaluation of HER2 status and intratumor heterogeneity in breast carcinoma

Published:2016-12 Issue:12 Volume:212 Page:1126-1132
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Arihiro Koji,Oda Miyo,Ogawa Katsunari,Kaneko Yoshie,Shimizu Tomomi,Tanaka Yuna,Marubashi Yukari,Ishida Katsunari,Takai Chikako,Taoka Chie,Kimura Shuji,Shiroma Noriyuki

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference35 articles.

1. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J. Clin. Oncol.,2013

2. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;Arch. Pathol. Lab. Med.,2014

3. HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity;Hanna;Mod. Pathol.,2014

4. Current challenges for HER2 testing in diagnostic pathology: state of the art and controversial issues;Sapino;Front. Oncol.,2013

5. Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines;Vance;Arch. Pathol. Lab. Med.,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS fluorescence in situ hybridisation testing for the detection and diagnosis of pancreatic adenocarcinoma;Journal of Clinical Pathology;2018-04-25